This “nanotransformer”vaccine was found to induce potent CD8+ T cell responsesand facilitate complete B16.F10 tumor regression in combination withcheckpoint blockade therapy in mice.134 These results highlight the interplay between polymer engineeringand immune recognition and inspires design principles for future polymeradjuvant applications. This evidence concerns the gene CD8A and neoplasm.